Bristol-Myers Squibb Company Ce (CELG-RI) NYSE
0.10
-0.002725(-2.62%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.10
-0.002725(-2.62%)
Currency In USD
| Market Cap | 47.03B |
| Enterprise Value | 63.07B |
| P/E Ratio | 0 |
| PEG Ratio | N/A |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0 |
| Fiscal Year | December 31, 2018 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.26 |
| Operating Margin | 0.34 |
| Return On Assets | 0.11 |
| Return On Equity | 0.62 |
| Revenue | 48.19B |
| Revenue/Share | 20.82 |
| Gross Profit | 31.76B |
| EBITDA | 19.24B |
| Net Income | 7.05B |
| Diluted EPS | 3.46 |
| Total Cash | 10.49B |
| Total Cash/Share | 6.45 |
| Total Debt | 46.43B |
| Total Debt/Equity | 3.29 |
| Current Ratio | 2.23 |
| Book Value Per Share | 8.4 |
| 52-Week Change | 237.33 |
| 52-Week High | 0.11 |
| 52-Week Low | 0.1 |
| Moving Average 50 Days | 0.1 |
| Moving Average 200 Days | 0.08 |
| Average Volume | 38,609.64 |
| Shares Outstanding | 2.04B |
| % Held by Institutions | 0.02 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |